|
1
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM, Hogarty MD, Bagarteii R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goto S, Umehara S, Gerbing RB, Stram DO,
Brodeur GM, Seeger RC, Lukens JN, Matthay KK and Shimada H:
Histopathology (International Neuroblastoma Pathology
Classification) and MYCN status in patients with peripheral
neuroblastic tumors: A report from the Children's Cancer Group.
Cancer. 92:2699–2708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Irwin MS and Park JR: Neuroblastoma:
Paradigm for precision medicine. Pediatr Clin North Am. 62:225–256.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park JR, Bagatell R, London WB, Maris JM,
Cohn SL, Mattay KK and Hogarty M; COG Neuroblastoma Committee, :
Children's Oncology Group's 2013 blueprint for research:
Neuroblastoma. Pediatr Blood Cancer. 60:985–993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brodeur GM: Molecular basis for
heterogeneity in human neuroblastomas. Eur J Cancer. 31A:505–510.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rak J, Milsom C and Yu J: Tissue factor in
cancer. Curr Opin Hematol. 15:522–528. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rickles FR: Mechanisms of cancer-induced
thrombosis in cancer. Pathophysiol Haemost Thromb. 35:103–110.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khorana AA, Kuderer NM, Culakova E, Lyman
GH and Francis CW: Development and validation of a predictive model
for chemotherapy-associated thrombosis. Blood. 111:4902–4907. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ay C, Dunkler D, Marosi C, Chiriac AL,
Vormittag R, Simanek R, Quehenberger P, Zielinski C and Pabinger I:
Prediction of venous thromboembolism in cancer patients. Blood.
116:5377–5382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mackman N: Triggers, targets and
treatments for thrombosis. Nature. 451:914–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Versteeg HH and Ruf W: Emerging insights
in tissue factor-dependent signaling events. Semin Thromb Hemost.
32:24–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaido T, Oe H, Yoshikawa A, Mori A, Arii S
and Imamura M: Tissue factor is a useful prognostic factor of
recurrence in hepatocellular carcinoma in 5-year survivors.
Hepatogastroenterology. 52:1383–1387. 2005.PubMed/NCBI
|
|
14
|
Han LY, Landen CN Jr, Kamat AA, Lopez A,
Bender DP, Mueller P, Schmandt R, Gershenson DM and Sood AK:
Preoperative serum tissue factor levels are an independent
prognostic factor in patients with ovarian carcinoma. J Clin Oncol.
24:755–761. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamashita H, Kitayama J, Ishikawa M and
Nagawa H: Tissue factor expression is a clinical indicator of
lymphatic metastasis and poor prognosis in gastric cancer with
intestinal phenotype. J Surg Oncol. 95:324–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matthay KK, Villablanca JG, Seeger RC,
Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT,
Brodeur GM, et al: Treatment of high-risk neuroblastoma with
intensive chemotherapy, radiotherapy, autologous bone marrow
transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
N Engl J Med. 341:1165–1173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castleberry RP, Pritchard J, Ambros P,
Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B,
Dicks-Mireaux C, Frappaz D, et al: The international neuroblastoma
risk groups (INRG): A preliminary report. Eur J Cancer.
33:2113–2116. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimada H, Ambros IM, Dehner LP, Hata J,
Joshi VV and Roald B: Terminology and morphologic criteria of
neuroblastic tumors: Recommendations by the International
Neuroblastoma Pathology Committee. Cancer. 86:349–363. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Theissen J, Boensch M, Spitz R, Betts D,
Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon
T, et al: Heterogeneity of the MYCN oncogene in neuroblastoma. Clin
Cancer Res. 15:2085–2090. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sierko E, Wojtukiewicz MZ, Zimnoch L and
Kisiel W: Expression of tissue factor pathway inhibitor (TFPI) in
human breast and colon cancer tissue. Thromb Haemost. 103:198–204.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eisenreich A, Bolbrinker J and Leppert U:
Tissue factor: A conventional or alternative target in cancer
therapy. Clin Chem. 62:563–570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khorana AA, Ahrendt SA, Ryan CK, Francis
CW, Hruban RH, Hu YC, Hostetter G, Harvey J and Taubman MB: Tissue
factor expression, angiogenesis, and thrombosis in pancreatic
cancer. Clin Cancer Res. 13:2870–2875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rao B, Gao Y, Huang J, Gao X, Fu X, Huang
M, Yao J, Wang J, Li W, Zhang J, et al: Mutations of p53 and K-ras
correlate TF expression in human colorectal carcinomas: TF
downregulation as a marker of poor prognosis. Int J Colorectal Dis.
26:593–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu JL, May L, Lhotak V, Shahrzad S,
Shirasawa S, Weitz JI, Coomber BL, Mackman N and Rak JW: Oncogenic
events regulate tissue factor expression in colorectal cancer
cells: Implications for tumor progression and angiogenesis. Blood.
105:1734–1741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Staton CA, Chetwood ASA, Cameron IC, Cross
SS, Brown NJ and Reed MW: The angiogenic switch occurs at the
adenoma stage of the adenoma carcinoma sequence in colorectal
cancer. Gut. 56:1426–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maciel EO, Carvalhal GF, da Silva VD,
Batista EL Jr and Garicochea B: Increased tissue factor expression
and poor nephroblastoma prognosis. J Urol. 182:1594–1599. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abdulkadir SA, Carvalhal GF, Kaleem Z,
Kisiel W, Humphrey PA, Catalona WJ and Milbrandt J: Tissue factor
expression and angiogenesis in human prostate carcinoma. Hum
Pathol. 31:443–447. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Callander NS, Varki N and Rao LV:
Immunohistochemical identification of tissue factor in solid
tumors. Cancer. 70:1194–1201. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ueno T, Toi M, Koike M, Nakamura S and
Tominaga T: Tissue factor expression in breast cancer tissues: Its
correlation with prognosis and plasma concentration. Br J Cancer.
83:164–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sawada M, Miyake S, Ohdama S, Matsubara O,
Masuda S, Yakumaru K and Yoshizawa Y: Expression of tissue factor
in non-small-cell lung cancers and its relationship to metastasis.
Br J Cancer. 79:472–477. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shigemori C, Wada H, Matsumoto K, Shiku H,
Nakamura S and Suzuki H: Tissue factor expression and metastatic
potential of colorectal cancer. Thromb Haemost. 80:894–898. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hamada K, Kuratsu J, Saitoh Y, Takeshima
H, Nishi T and Ushio Y: Expression of tissue factor correlates with
grade of malignancy in human glioma. Cancer. 77:1877–1883. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rickles FR, Hair GA, Zeff RA, Lee E and
Bona RD: Tissue factor expression in human leukocytes and tumor
cells. Thromb Haemost. 74:391–395. 1995.PubMed/NCBI
|
|
34
|
Amirkhosravi A, Meyer T, Chang JY, Amaya
M, Siddiqui F, Desai H and Francis JL: Tissue factor pathway
inhibitor reduces experimental lung metastasis of B16 melanoma.
Thromb Haemost. 87:930–936. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Palumbo JS, Talmage KE, Massari JV, La
Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M and Degen JL:
Platelets and fibrin(ogen) increase metastatic potential by
impeding natural killer cell-mediated elimination of tumor cells.
Blood. 105:178–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Abe K, Shoji M, Chen J, Bierhaus A, Danave
I, Micko C, Casper K, Dillehay DL, Nawroth PP and Rickles FR:
Regulation of vascular endothelial growth factor production and
angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl
Acad Sci USA. 96:8663–8668. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dorfleutner A, Hintermann E, Tarui T,
Takada Y and Ruf W: Cross-talk of integrin alpha3beta1 and tissue
factor in cell migration. Mol Biol Cell. 15:4416–4425. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Seto S, Onodera H, Kaido T, Yoshikawa A,
Ishigami S, Arii S and Imamura M: Tissue factor expression in human
colorectal carcinoma: Correlation with hepatic metastasis and
impact on prognosis. Cancer. 88:295–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou JN, Ljungdahl S, Shoshan MC,
Swedenborg J and Linder S: Activation of tissue-factor gene
expression in breast carcinoma cells by stimulation of the RAF-ERK
signaling pathway. Mol Carcinog. 21:234–243. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Poon RT, Lau CP, Ho JW, Yu WC, Fan ST and
Wong J: Tissue factor expression correlates with tumor angiogenesis
and invasiveness in human hepatocellular carcinoma. Clin Cancer
Res. 9:5339–5345. 2003.PubMed/NCBI
|
|
41
|
Ueda C, Hirohata Y, Kihara Y, Nakamura H,
Abe S, Akahane K, Okamoto K, Itoh H and Otsuki M: Pancreatic cancer
complicated by disseminated intravascular coagulation associated
with production of tissue factor. J Gastroenterol. 36:848–850.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Versteeg HH, Spek CA, Peppelenbosch MP and
Richel DJ: Tissue factor and cancer metastasis: The role of
intracellular and extracellular signaling pathways. Mol Med.
10:6–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Koomägi R and Volm M: Tissue-factor
expression in human non-small-cell lung carcinoma measured by
immunohistochemistry: Correlation between tissue factor and
angiogenesis. Int J Cancer. 79:19–22. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lykke J and Nielsen HJ: The role of tissue
factor in colorectal cancer. Eur J Surg Oncol. 29:417–422. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Poon RT, Lau CP, Cheung ST, Yu WC and Fan
ST: Quantitative correlation of serum levels and tumor expression
of vascular endothelial growth factor in patients with
hepatocellular carcinoma. Cancer Res. 63:3121–3126. 2003.PubMed/NCBI
|
|
46
|
Nitori N, Ino Y, Nakanishi Y, Yamada T,
Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M and Hirohashi
S: Prognostic significance of tissue factor in pancreatic ductal
adenocarcinoma. Clin Cancer Res. 11:2531–2539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Akashi T, Furuya Y, Ohta S and Fuse H:
Tissue factor expression and prognosis in patients with metastatic
prostate cancer. Urology. 62:1078–1082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kakkar AK, Lemoine NR, Scully MF, Tebbutt
S and Williamson RC: Tissue factor expression correlates with
histological grade in human pancreatic cancer. Br J Surg.
82:1101–1104. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schwab M, Shimada H, Joshi V and Brodeur
GM: Neuroblastic tumors of adrenal glandand sympathetic nervous
systemPathology and Genetics of Tumors of the Nervous System.
Kleihues P and Cavenee WK: World Health Organization, IARC; Lyon:
pp. 153–161. 2000
|
|
50
|
Maris JM, Weiss MJ, Guo C, Gerbing RB,
Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN,
et al: Loss of heterozygosity at 1p36 independently predicts for
disease progression but not decreased overall survival probability
in neuroblastoma patients: A Children's Cancer Group study. J Clin
Oncol. 18:1888–1899. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Silva DD, Noronha JA, Silva VD and
Carvalhal GF: Increased tissue factor expression is an independent
predictor of mortality in clear cell carcinoma of the kidney. Int
Braz J Urol. 40:499–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zwicker Jl, Furie BC and Furie B:
Cancer-associated thrombosis. Crit Rev Oncol Hematol. 62:126–136.
2007. View Article : Google Scholar : PubMed/NCBI
|
